Cyclooxygenase-2 Expression in Stromal Tumors of the Gastrointestinal Tract

Human Pathology

Volumn 34, Issue 12, 2003, Pages 1242-1246

  Sheehan, Katherine M ^a   Sabah, Muna ^a   Cummins, Robert J ^a   O'Grady, Anthony ^a   Murray, Frank E ^a   Leader, Mary B ^a   Kay, Elaine W ^a  

^a BEAUMONT HOSPITAL   (Ireland)

Author keywords

Aspirin; Cyclooxygenase; Gastrointestinal stromal tumor

Indexed keywords

ARACHIDONIC ACID; CD68 ANTIGEN; CYCLOOXYGENASE 2; EOSIN; HEMATOXYLIN; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTACYCLIN DERIVATIVE; PROSTAGLANDIN DERIVATIVE; STEM CELL FACTOR RECEPTOR; THROMBOXANE;

ARTICLE; CANCER SURVIVAL; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPLASM; DNA MICROARRAY; ENZYME ANALYSIS; EPITHELIUM CELL; EPITHELIUM TUMOR; EVALUATION; GASTROINTESTINAL TUMOR; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PATHOGENESIS; PROTEIN EXPRESSION; SPINDLE CELL; STAINING; STROMA CELL; TISSUE SPECIFICITY; TUMOR ASSOCIATED LEUKOCYTE; TUMOR LOCALIZATION;

EID: 0346362438     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2003.01.001     Document Type: Article

References (40)

1. Smith WL: Prostanoid biosynthesis and mechanisms of action. Am J Physiol 263:181-191, 1992
2. DuBois RN, Tsujii M, Bishop P, et al: Cloning and characterization of growth factor inducible cyclooxygenase gene from rat intestinal epithelial cells. Am J Physiol 266:G822-G827, 1994
3. Jones DA, Carlton DP, McIntyre TM, et al: Molecular cloning of human endoperoxide synthase type II and demonstration of expression in response to cytokines. J Biol Chem 268:9049-9054, 1993
4. Williams CD, Mann M, Dubois RN: The role of cyclooxygenases in inflammation, cancer and development. Oncogene 18:7908-7916, 1999
5. Trifan OC, Smith RM, Thompson BD, et al: Overexpression of cyclooxygenase-2 induces cell cycle arrest. J Biol Chem 274:34141-34147, 1999
6. Tsujii M, DuBois RN: Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell 83:493-501, 1995
7. Jones MK, Wang H, Peskar BM, et al: Inhibition of angiogenesis by NSAIDs: Insight into the mechanisms and implications for cancer growth and ulcer healing. Nat Med 5:1418-1423, 1999
8. Coffey RJ, Hawkey CJ, Damstrup L, et al: Epidermal growth factor receptor activation induces nuclear targeting of cyclooxygenase-2, basolateral release of prostaglandins and mitogenesis in polarizing colon cancer cells. Proc Natl Acad Sci U S A 94:657-662, 1997
9. Bakhle YS: COX-2 and cancer: A new approach to an old problem. Br J Pharm 134:1137-1150, 2001
10. Mazur MT, Clark MB: Gastric stromal tumors: Reappraisal of histogenesis. Am J Surg Pathol 7:507-519, 1983
11. Sarlomo RM, Kovatich AJ, Baruseviciius A, et al: CD117: A sensitive marker for gastrointestinal stromal tumors that is more specific than CD34. Mod Pathol 11:728-734, 1998
12. Kindblom L-G, Remotti HE, Aldenborg F, et al: Gastrointestinal pacemaker cell tumor (GIPACT): Gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal. Am J Pathol 152:1259-1269, 1998
13. Hirota S, Isozaki K, Moriayama Y, et al: Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science 279:577-580, 1998
14. De Matteo RP, Heinrich MC, El-Rifai, et al. Clinical management of gastrointestinal stromal tumors: Before and after STI-571. HUM PATHOL 33:466-477, 2002
15. Thomas RM, Sobin LH: Gastrointestinal cancer incidence and prognosis by histologic type, SEER population based data 1973-1987. Cancer 75:154-170, 1995
16. Fletcher CDM, Berman JJ, Corless C, et al: Diagnosis of gastrointestinal stromal tumors: A consensus approach. HUM PATHOL 33:459-465, 2002
17. DeMatteo RP, Lewis JJ, Leung D, et al: Two hundred gastrointestinal stromal tumors: Recurrence patterns and prognostic factors for survival. Ann Surg 231:51-58, 2000
18. Porcher C, Horowitz B, Bayguinov O, et al: Constitutive expression and function of cyclooxygenase-2 in murine gastric muscles. Gastroenterology 122:1442-1454, 2002
19. Shiff SJ, Rigas B: The role of cyclooxygenase inhibition in the anti-neoplastic effects of nonsteroidal anti-inflammatory drugs (NSAIDs). J Exp Med 190:445-450, 1999
20. Steinbach G, Lynch PM, Phillips RK, et al: The effect of celecoxib, a cyclooxygenase inhibitor, in familial adenomatous polyposis. N Engl J Med 342:1946-1952, 2000
21. Miettinen M, El-Rifai W, Sobin LH, et al: Evaluation of malignancy and prognosis of GISTS: A review. HUM PATHOL 33:478-483, 2002
22. Kononen J, Bubendorf L, Kallioniemi A, et al: Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 4:844-847, 1998
23. Gulmann C, Butler D, Kay E, et al: Biopsy of a biopsy: Validation of immunoprofiling in gastric cancer biopsy tissue microarrays. Histopathology, 42:70-76, 2002
24. Hull MA, Booth JK, Tisbury A, et al: Cyclooxygenase-2 is up regulated and localised to macrophages in the intestine of Min mice. Br J Cancer 79:1399-1405, 1999
25. Shattuck-Brandt RL, Varilek GW, Radhika A, et al: Cyclooxygenase 2 expression is increased in the stroma of colon carcinomas from IL-10 (-/-) mice. Gastroenterology 118:337-345, 2000
26. Nolan RD, Danilowicz RM, Eling TE: Role of arachidonic acid metabolism in mitogenic response of BALB/c 3T3 fibroblasts to epidermal growth factor. Mol Pharmacol 33:650-656, 1988
27. Lewis JS, Landers RJ, Underwood JC, et al: Expression of vascular endothelial growth factor by macrophages is regulated in poorly vascularized areas of breast carcinomas. J Pathol 192:150-158, 2000
28. Huang ZF, Massey JB, Via DP: Differential regulation of cyclooxygenase-2 (COX-2) mRNA by interleukin-1 beta and tumor necrosis factor alpha in human in vitro differentiated macrophages. Biochem Pharmacol 59:187-194, 2000
29. Kinzler KW, Vogelstein B: Lessons from hereditary colon cancer. Cell 87:159-170, 1996
30. Thun MJ, Namboodiri MM, Calle EE, et al: Aspirin use and the risk of fatal cancer. Cancer Res 53:1322-1327, 1993
31. Δ716 knockout mice by inhibition of cyclooxygenase-2 (COX-2). Cell 87:803-809, 1996
32. Shiff SJ, Qiao L, Tsai L, et al: Sulindac sulfide, an aspirin-like compound, inhibits proliferation, causes cell cycle quiescence and induces apoptosis in HT-29 colon adenocarcinoma cells. J Clin Invest 96:491-503, 1995
33. Tsujii M, Kawano S, DuBois RN: Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. Proc Natl Acad Sci USA 94:3336-3340, 1997
34. Sheehan KM, Sheahan K, O'Donoghue DP, et al: The relationship between cyclooxygenase-2 expression and colorectal cancer. JAMA 282:1254-1257, 1999
35. Matsumoto Y, Ishiko O, Sumi T, et al: Cyclooxygenase-2 expression in malignant mesenchymal tumors and related uterine lesions. Oncol Rep 8:1225-1227, 2001
36. Edwards JG, Faux SP, Plummer SM, et al: Cyclooxygenase-2 expression is a novel prognostic factor in malignant mesothelioma. Clin Cancer Res 8:1857-1862, 2002
37. Dickens DS, Kozielski R, Khan J, et al: Cyclooxygenase-2 expression in pediatric sarcomas. Pediatr Dev Pathol 5:356-364, 2002
38. Hoferova Z, Fedorocko P, Hofmanova J, et al: The effect of non-steroidal anti-inflammatory drugs ibuprofen, flurbiprofen, and diclofenac on in vitro and in vivo growth of mouse fibrosarcoma. Cancer Invest 20:490-498, 2002
39. Ferrario A, Von Tiehl K, Wong S, et al: Cyclooxygenase-2 inhibitor treatment enhances photodynamic therapy mediated tumor response. Cancer Res 62:3956-3961, 2002
40. Cuendet M, Pezzuto JM: The role of cyclooxygenase and lipoxygenase in cancer chemoprevention. Drug Metabol Drug Interact 17:109-157, 2000